Caricamento...
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
Olodaterol (BI 1744 CL) is a novel, once-daily long-acting β(2)-agonist (LABA) designed with the aim of improving β(2)-adrenoreceptor selectivity and intrinsic activity. Phase III pivotal trials have documented that olodaterol Respimat Soft Mist inhaler 5 μg induces fast onset of bronchodilation, co...
Salvato in:
| Pubblicato in: | Ther Clin Risk Manag |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4675639/ https://ncbi.nlm.nih.gov/pubmed/26676161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S73581 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|